Raymond Woo-Jun Jang - Researcher Profile

Publications

2 shown

Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer

Charles S. Fuchs , Toshihiko Doi , Raymond Woo-Jun Jang +26 more

IMPORTANCE Therapeutic options are needed for patients with advanced gastric cancer whose disease has progressed after 2 or more lines of therapy. OBJECTIVE To evaluate the safe...

2018 JAMA Oncology 1757 citations

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

Ezra E.W. Cohen , Denis Soulières , Christophe Le Tourneau +97 more

There are few effective treatment options for patients with recurrent or metastatic head-and-neck squamous cell carcinoma. Pembrolizumab showed antitumour activity and manageabl...

2018 The Lancet 1593 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 3,350
Institution: Princess Margaret Cancer Centre

External Links

Google Scholar

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.